Loading...
Skip to Content

Vertex Pharmaceuticals Inc

Provider: Exchange
Annualised Return 15.23%
Realised Volatility 38.2%
Downside Volatility 21.2%
Max Drawdown -55.08%
Winning months 54.42%
Sharpe Ratio 0.4
Sortino Ratio 0.72
Calmar Ratio 0.28
Viking Ratio 0.25
Monthly performance
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec YTD
2024 6.51% -2.92% -0.65% -6.03% 15.92% 2.94% 5.76% 0.03% -6.21% 2.34% -5.88% 10.11%
2023 11.88% -10.15% 8.54% 8.14% -5.04% 8.76% 0.12% -1.14% -0.17% 4.13% -2.02% 14.68% 40.9%
2022 10.68% -5.36% 13.46% 4.69% -1.67% 4.89% -0.49% 0.48% 2.76% 7.76% 1.41% -8.73% 31.5%
2021 -3.07% -7.22% 1.1% 1.54% -4.39% -3.36% -0.02% -0.64% -9.44% 1.95% 1.09% 17.47% -7.08%
2020 3.7% -1.33% 6.21% 5.57% 14.63% 0.82% -6.31% 2.62% -2.51% -23.43% 9.31% 3.77% 7.94%
2019 15.21% -1.13% -2.54% -8.14% -1.66% 10.35% -9.14% 8.04% -5.89% 15.38% 13.44% -1.26% 32.13%
2018 11.35% -0.5% -1.84% -6.03% 0.55% 10.36% 2.99% 5.34% 4.52% -12.08% 6.69% -8.34% 10.58%
2017 16.56% 5.53% 20.67% 8.18% 4.48% 4.26% 17.81% 5.74% -5.29% -3.82% -1.33% 3.86% 103.42%
2016 -27.88% -5.8% -7.02% 6.1% 10.45% -7.65% 12.76% -2.57% -7.72% -13.01% 7.58% -9.73% -41.45%
2015 -7.29% 8.43% -1.22% 4.5% 4.06% -3.75% 9.33% -5.54% -19.04% 20.83% 3.7% -2.73% 5.92%
2014 6.38% 2.3% -12.54% -4.27% 6.74% 31.03% -6.09% 5.24% 20.03% 0.29% 4.65% 0.78% 59.89%
2013 6.87% 4.56% 17.43% 39.72% 4.57% -0.34% -0.32% -5.83% 0.89% -5.9% -2.63% 6.95% 77.33%
2012 11.26% 5.33% 5.37% -6.17% 56.03% -6.86% -13.25% 9.89% 4.84% -13.62% -17.58% 5.3% 26.17%
2011 11.02% 20.01% 2.7% 14.85% -1.93% -3.7% -0.25% -12.71% -1.79% -10.95% -26.77% 14.56% -5.2%
2010 -10.39% 5.57% 0.81% -5.14% -10.78% -4.89% 2.31% -1.04% 3.78% 10.79% -13.5% 5.73% -18.25%
2009 8.79% -8.8% -4.68% 7.27% -3.41% 20.83% 0.11% 3.89% 1.31% -11.45% 15.67% 10.38% 41.05%
2008 -12.35% -14.05% 36.51% 6.82% 12.19% 16.91% 3.08% -22.14% 23.75% -21.15% -6.18% 23.55% 30.78%
2007 -4.44% -13.18% -8.63% 9.63% -2.73% -4.48% 13.1% 20.62% -1.41% -15.8% -21.49% -8.51% -37.21%
*Performance is net of rebalancing costs, fixed fees (0% annually) and performance fees (0% over high watermark).